 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Medicine > Protein Design Labs, Inc.
 |
Protein Design Labs, Inc. |
 |
 |
 |
NEWS FROM THE WIRES |
 |
RESEARCH ALERT-Lehman cuts outlook for Protein Design Aug 03 2001 08:57 AM PDT
Before The Bell - Sensormatic firmer, but futures weak Aug 03 2001 06:03 AM PDT
Before The Bell - Futures sag, Sensormatic jumps Aug 03 2001 05:13 AM PDT
Arch Wireless says units default on debt, bank line Aug 02 2001 03:45 PM PDT
After The Bell-Walt Disney rises, some biotechs slump Aug 02 2001 02:41 PM PDT
> More WIRE STORIES about this company
NEWS FROM THE STANDARD |
 |
Investors Hear Evil, See Evil, Thumb Their Noses at Evil
Jan 17 2001 11:36 AM PST
PROFILE |
 |
If your body starts fighting you, Protein Design Labs hopes to help you fight right back. The firm develops humanized monoclonal antibodies to prevent and treat autoimmune diseases, inflammatory conditions, cancers, and other conditions. Its flagship product, Zenapax, fights kidney transplant rejection and is licensed to drug giant Roche. The drug is also being tested for the treatment of autoimmune disease, psoriasis, and uveitis (inflammation of the eye). Protein Design Labs has several other compounds in clinical trials. The firm has collaborative agreements with such companies as Eli Lilly and Yamanouchi Pharmaceutical.
COMPETITION |
 |
Corixa Corporation (CRXA)
MedImmune, Inc. (MEDI)
Novartis AG (NVS)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 39.90
1-Yr. Sales Growth: 48.9%
Employees: 307
Revenue per employee: $129,967.43
KEY PEOPLE |
 |
Laurence J. Korn
CEO
Robert L. Kirkman
CFO
CONTACT INFO |
 |
34801 Campus Dr.
Fremont, CA 94555
US
Phone: 510-574-1400
Fax: 510-574-1500
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |